Global Integrated PR Integrated communications programs that combine investor relations, public relations, and marketing position LaVoieHealthScience to serve health science innovators seeking both market visibility and fundraising support. With the Omnicom Public Relations Group alliance, they offer global scale and high touch service, making them a fit for biotech, pharma, and medical technology brands pursuing campaigns across markets.

Leadership Growth Recent leadership additions indicate a deliberate expansion strategy and readiness to scale client programs, including senior level PR leadership in Boston. This signals capacity to handle larger accounts or complex campaigns and provides a conversation starter for mid market clients seeking proven program leadership and regional coverage.

Global Campaign Reach Global reach through Omnicom network and 2,000 health expert consultants across 100 countries enables cross border product launches, investor roadshows, and regulatory communications at scale. This makes LHS an attractive partner for companies planning international campaigns or multi country investor relations efforts.

Credibility and Awards Strong credibility evidenced by 30 plus awards and recognition as a top independent healthcare PR agency and Inc 5000 fastest growing company. Prospects can leverage this track record to attract media attention, secure stakeholder engagement, and demonstrate ROI to investors.

Mid Market Advantage Established revenue size and 18 years of healthcare communications experience with 300 proven strategies position LaVoieHealthScience to serve mid market life sciences firms in public health, biotech, pharma, and medtech. The offering can be bundled as integrated PR and investor relations programs with measurable ROI, leveraging tools like Cision for media monitoring and analytics.